Join us for this primer on the fundamentals of pharmaceutical pricing related to government payor programs and obtain an in-depth working knowledge of these programs which will lay the foundation for the more in-depth discussions that will take place throughout the main conference. Points of discussion will include:

• Reviewing applicable legislation such as the IRA, MMA, DRA, ACA, and recently enacted IRA and key agency rules/guidance
• Tracking the flow of payments and reimbursements in the health care supply chain
  • Identifying stakeholders within the chain and their roles
  • Tracking the flow of drugs, payments, and services
• Deciphering commonly used acronyms and terminology
• Surveying the different pricing benchmarks and calculations
  • AMP, AWP, ASP, WAC, BP, PHS, FCP, and non-FAMP
• Understanding the implications of different pricing methodologies, calculations, and benchmarks for different stakeholders
• Examining the key pricing concepts and calculations for government drug pricing and rebate programs
  • Medicaid Drug Rebate program
  • Medicare Part B and D
  • 340B Drug Pricing program
  • Federal Supply Schedule/Federal Ceiling Price
  • TRICARE
• Considering the interactions among the programs
• Understanding how participation in the Medicaid Drug Rebate Program impacts participation in the PHS 340B program